Back to search

University of Leeds

Exploring complementary proteomic approaches for biomarker discovery in renal cell carcinoma

Abstract

dc:description.abstract

Renal cell carcinoma (RCC) is one of the top ten most common malignancies worldwide. The field of clinical proteomics has seen successes in recent years, and advancements in technology is making ever more possible the ability to answer clinical questions. This study used proteomics to investigate two key clinical questions in RCC biology. Firstly, two comparative studies were performed to investigate biomarkers that may predict response to sunitinib, the predominant drug used to treat metastatic RCC. Serum (12 patients) and FFPE tissue (16 patients) samples from sunitinib responding and non-responding patients were analysed by liquid chromatography-tandem mass spectrometry (LC-MS/MS), to discover novel markers of response. Two candidate biomarkers were initially validated using Western blot or immunohistochemistry. Two serum (IGFBP5, CDH1) and two FFPE tissue (CD70, hCAP18) proteins were identified as promising candidate biomarkers, initial validation of CD70 and hCAP18 was performed. Secondly, furthering the understanding of RCC biology may improve rational drug design and biomarker identification. Five cell lines carrying mutations of VHL, the predominant tumour suppressor gene in RCC, were compared to investigate the proteomic impact of VHL mutation. The scaffold protein IRS2 was identified as highly expressed in the absence of VHL, and this protein was initially validated by Western blot in in vitro cell lines. The techniques used in this study revealed logical biological alterations, of which three proteins were validated using an independent technique. Further validation of the identified proteins is on-going, with the hope that they may impact upon patient care. The advantages and disadvantages of the proteomic analysis of serum, FFPE tissue, and in vitro cell lines is discussed.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Leeds
Year dc:date.issued
2015

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Shreeve, Rebecca Louise
Advisors dc:contributor.advisor
  • Banks, Roz
  • Vasudev, Naveen
  • Zougman, Alexandre
  • Selby, Peter

Rights

Language dc:language.dcterms_iso639_2
eng

Identifiers

dc:identifier.*
Identifier
uk.bl.ethos.677290

Chain of custody

source
Harvested from
White Rose University Consortium
Base URL
etheses.whiterose.ac.uk/cgi/oai2
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Shreeve, Rebecca Louise. Exploring complementary proteomic approaches for biomarker discovery in renal cell carcinoma. doctoral thesis, University of Leeds, 2015. https://etheses.whiterose.ac.uk/id/eprint/11120/3/S2.%20Proteingroups_Longitudinal%20serum.xlsx